In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.
Learn more about our policy
The executive team
News & Events
News & Publications
Our latest news
Clinical trial shows major positive effect of food supplement in hospitalised patients with COVID-19
Osteoarthritis endotype discovery via clustering of biochemical marker data
Our next events
No information to display right now.
I have samples collected from a previous study, can you test them?
Do you provide veterinary clinical studies?
Do you have tools to promote patient recruitment?
"We compared several companies to perform our biomarker assays. We chose Artialis for their competitive prices and their ability to start analysis in a very short time.
The team was very responsive and gave us updates throughout the process. Moreover, the work was carried out on time."
R&D Associate - Confidential Company
"We chose Artialis because of their expertise in the design of in vivo protocol specialized in osteoarthritis. Moreover, it was very well written and Artialis team inspired a lot of confidence.
[We liked] their dedication to our project, their knowledge in osteoarthritis, their access to a state of the art facility, [and] their knowledge in vivo design protocol (...) I would highly recommend the services of Artialis mainly for their high quality and high involvement. "
R&D Project Manager - Confidential Company
"We wanted to know whether oral treatment with polyphenols could decreased serum level of OA biomarkers in DMM mice model and needed results quickly. [Artialis has offered] robust skills, reactivity, and possibility to academic collaboration."
PhD Candidate - INSERM U791, Laboratoire d'Ingénierie Ostéo-Articulaire et Dentaire (France)
"Since the biomarker world is very competitive, every work involving new biomarkers should be previously and accurately discussed to tune the interests of the Sponsor with those of Artialis.
They are on time and flexible [and have] the ability to focus rapidly on the Sponsor requirement.
[We appreciate the] reliability of data and the open and timely communication. "
Director Pharmacology & Toxicology - Rottapharm Biotech (Italy)
"We needed a specific measure for the cartilage degeneration to prove the efficacy of our product. The collaboration with Artialis was a logical choice. "
Sales & Marketing Director - Tilman (Belgium)
Sign in newsletter
Please enter your name and email address in order to receive our newsletter.
Artialis respects your privacy. Your data will not be shared with any third party.
11, Avenue de l'Hôpital
Tour GIGA +3
4000 Liège (Sart-Tilman), Belgium
Business Registration Number: 0830584472
Tel. +32 4 242 77 27
Fax +32 4 242 77 28
For any question, request or order of ELISA kits, please contact our customer service at
Find us :
© Artialis - All rights reserved
Terms & conditions